These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 33590521)

  • 41. Global Polio Eradication,The Journey So Far.
    Thacker N; Yewale VN; Pathak A
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S61-S64. PubMed ID: 27771642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of Global Alliance for Vaccines and Immunization (GAVI) in Accelerating Inactivated Polio Vaccine Introduction.
    Thacker N; Thacker D; Pathak A
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S57-S60. PubMed ID: 27771641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polio Eradication Initiative: Contribution to improved communicable diseases surveillance in WHO African region.
    Mwengee W; Okeibunor J; Poy A; Shaba K; Mbulu Kinuani L; Minkoulou E; Yahaya A; Gaturuku P; Landoh DE; Nsubuga P; Salla M; Mihigo R; Mkanda P
    Vaccine; 2016 Oct; 34(43):5170-5174. PubMed ID: 27389170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The global polio eradication initiative: lessons learned and prospects for success.
    Aylward B; Tangermann R
    Vaccine; 2011 Dec; 29 Suppl 4():D80-5. PubMed ID: 22486981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multi-pronged scoping review approach to understanding the evolving implementation of the Smallpox and Polio eradication programs: what can other Global Health initiatives learn?
    Schleiff M; Olateju A; Decker E; Neel AH; Oke R; Peters MA; Rao A; Alonge O
    BMC Public Health; 2020 Dec; 20(Suppl 4):1698. PubMed ID: 33339517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polio endgame: the global introduction of inactivated polio vaccine.
    Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
    Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Global surveillance and the value of information: the case of the global polio laboratory network.
    de Gourville E; Duintjer Tebbens RJ; Sangrujee N; Pallansch MA; Thompson KM
    Risk Anal; 2006 Dec; 26(6):1557-69. PubMed ID: 17184397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The polio endgame.
    Minor P
    Hum Vaccin Immunother; 2014; 10(7):2106-8. PubMed ID: 25608050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oversight role of the Independent Monitoring Board of the Global Polio Eradication Initiative.
    Rutter PD; Donaldson LJ
    J Infect Dis; 2014 Nov; 210 Suppl 1():S16-22. PubMed ID: 25316831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of in-country capacity to maintain communicable disease surveillance and response services after polio eradication-Somalia.
    Hsu CH; Harvey B; Mohamed A; Elfakki E; Ehrhardt D; Farag NH
    Vaccine; 2020 Jan; 38(5):1220-1224. PubMed ID: 31753675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Placing Human Behavior at the Center of the Fight to Eradicate Polio: Lessons Learned and Their Application to Other Life-Saving Interventions.
    Guirguis S; Obregon R; Coleman M; Hickler B; SteelFisher G
    J Infect Dis; 2017 Jul; 216(suppl_1):S331-S336. PubMed ID: 28838157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. From legacy to integration in the Global Polio Eradication Initiative: looking back to look forward.
    Closser S; Neel AH; Gerber S; Alonge O
    BMJ Glob Health; 2024 May; 9(5):. PubMed ID: 38770815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
    Thompson KM; Tebbens RJ
    Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. World could be declared free of polio by 2018.
    Gulland A
    BMJ; 2013 Apr; 346():f2373. PubMed ID: 23585234
    [No Abstract]   [Full Text] [Related]  

  • 56. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper.
    Wkly Epidemiol Rec; 2010 Jun; 85(23):213-28. PubMed ID: 20545051
    [No Abstract]   [Full Text] [Related]  

  • 57. The costs of future polio risk management policies.
    Tebbens RJ; Sangrujee N; Thompson KM
    Risk Anal; 2006 Dec; 26(6):1507-31. PubMed ID: 17184394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polio endgame: Lessons for the global rotavirus vaccination program.
    Jiang B; Patel M; Glass RI
    Vaccine; 2019 May; 37(23):3040-3049. PubMed ID: 31027927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inactivated polio vaccine: time to introduce it in India's national immunization schedule.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2012 Jul; 8(7):956-8. PubMed ID: 22699444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Global polio eradication: Where are we in Europe and what next?
    Celentano LP; Carrillo-Santisteve P; O'Connor P; Danielsson N; Huseynov S; Derrough T; Adel Ali K; Butler R; Greco D
    Vaccine; 2018 Aug; 36(36):5449-5453. PubMed ID: 28477852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.